Mechanistically, IGF2BP3 could serve as an m6A “reader” to recognize m6A modified mRNA and enhance HDGF mRNA stability to promote tumor angiogenesis and glycolysis in GC [15]. The gene discussed is IGF2BP3; the disease is gastric cancer.